| HLA Allele |
Controls n = 524 |
LTI n = 218 |
PTB n = 318 |
|
|
|
| HLA-C* |
n (%) |
n (%) |
n (%) |
Pa |
OR |
95%CI |
| 01 |
18 (3.44) |
8 (3.67) |
18 (5.66) |
|
|
|
| 02 |
36 (6.87) |
11 (5.05) |
15 (4.72) |
|
|
|
| 03 |
48 (9.16) |
18 (8.26) |
31 (9.75) |
|
|
|
| 04 |
75 (14.31) |
29 (13.30) |
38 (11.95) |
|
|
|
| 05 |
37 (7.06) |
16 (7.34) |
22 (6.92) |
|
|
|
| 06 |
36 (6.87) |
15 (6.88) |
18 (5.66) |
|
|
|
| 07 |
134 (25.57) |
49 (22.45) |
79 (24.84) |
|
|
|
| 08 |
28 (5.34) |
13 (5.96) |
31 (9.75) |
0.022 |
1.91 |
1.12-3.25 |
| 12 |
26 (4.96) |
14 (6.42) |
12 (3.77) |
|
|
|
| 14 |
6 (1.14) |
7 (3.21) |
9 (2.83) |
|
|
|
| 15 |
26 (4.96) |
16 (7.34) |
13 (4.09) |
|
|
|
| 16 |
50 (9.54) |
21 (9.63) |
30 (9.43) |
|
|
|
| 17 |
4 (0.76) |
1 (0.46) |
4 (1.26) |
|
|
|
aUncorrected p value. After Bonferroni correction for multiple comparisons p values
were not significant
No significant differences were obtained when we compared the other groups. One
PTB patient could not be HLA typed and for this reason in all the tables n is 318
instead 320. |
